Show an ad over header. AMP

New data finds first Pfizer dose is highly effective, can be stored in normal freezers

Pfizer's coronavirus vaccine may be more effective after just one shot than researchers had previously realized, and can be stored for two weeks at standard temperatures typically found in pharmaceutical freezers and refrigerators, according to new data.

Why it matters: The findings about first-dose efficacy, which appear in a new analysis published in The Lancet, appear to support a strategy of delaying second shots in order to make the most of limited supplies. That's what the U.K. has done, and some experts have called for a similar approach in the U.S.

Separately, Pfizer and BioNtech's announcement that vaccine vials can be stored and transported at -25°C to-15°C (-13°F to 5°F) could allow the vaccine to be handled by ordinary pharmacies that aren't equipped with ultra-low freezers, which have been an impediment in the vaccine rollout.

  • The companies said that they had submitted a proposed update to the FDA's emergency use authorization to allow the vaccine to be stored at these temperatures "as an alternative or complement to storage in an ultra-low temperature freezer."

Details: Pfizer's clinical trials initially showed that its vaccine prevented roughly 52% of infections after one dose, rising to 95% after two doses.

  • The new research published in The Lancet, however, found that the first shot of Pfizer's vaccine actually prevented about 75% of infections, and 85% of symptomatic infections, up to 28 days after it was administered.
  • The findings were based on an evaluation of about 9,000 people in Israel, which has vaccinated over two-thirds of its adult population, The Wall Street Journal reports.

Yes, but: There are some limitations to this study and its implications for delaying second doses.

  • Although the first dose appeared to be more powerful than originally anticipated, researchers still don't know how long its effects will last.
  • Pfizer recommends getting the second dose 21 days after the first one. The Israeli study measured the efficacy of the first shot within 15 to 28 days of its administration — not a significant delay. And most participants in the trial did receive their second shots, the authors told the WSJ.

The big picture: Most of the people in this study got their second doses, and got those doses on time. Second doses were not delayed in this case, and so this study does not directly answer the question of what happens when you delay second doses.

  • The findings will bolster calls to delay second doses because they indicate that first doses are more effective than we realized — making a compelling case to get that level of protection to as many people as possible as quickly as possible, to save lives and bring the pandemic under control.

U.S. grants temporary protected status to thousands of Venezuelans

Venezuelans living in the United States will be eligible to receive temporary protected status for 18 months, the Department of Homeland Security announced Monday.

Why it matters: Tens of thousands of Venezuelans have fled to the U.S. amid economic, political and social turmoil back home. Former President Trump, on his last full day in office, granted some protections to Venezuelans through the U.S. Deferred Enforced Departure program, but advocates and lawmakers said the move didn't go far enough.

Keep reading... Show less

Zuckerberg floated possibility of remote work in January 2020. Sandberg thought he was "nuts"

Chief operating officer Sheryl Sandberg thought Mark Zuckerberg was "nuts" when he raised the possibility in January 2020 that 50,000 Facebook employees might have to work from home. By March 6, they were.

Why it matters: In an interview Monday with Axios Re:Cap, Sandberg explained how Facebook moved quickly to respond to the pandemic with grants for small businesses and work-from-home stipends for its employees, and how the company has been watching the unfolding crisis for women in the workforce.

Keep reading... Show less

Supreme Court declines to hear case on qualified immunity for police officers

The Supreme Court on Monday declined to hear an appeal for a lawsuit brought against Cleveland police officers that challenges the scope of qualified immunity, the legal doctrine which has been used to shield officers from lawsuits alleging excessive force, Reuters reports.

Why it matters: The doctrine has been the subject of scrutiny from civil rights advocates. Eliminating qualified immunity was one of the key demands of demonstrators during nationwide protests in 2020 following the killing of George Floyd.

Keep reading... Show less

CDC: Fully vaccinated people can gather indoors without masks

People who have been fully vaccinated against COVID-19 can take fewer precautions in certain situations, including socializing indoors without masks when in the company of low-risk or other vaccinated individuals, according to guidance from the Centers for Disease Control and Prevention released Monday.

Why it matters: The report cites early evidence that suggests vaccinated people are less likely to have asymptomatic infection, and are potentially less likely to transmit the virus to other people. At the time of its publication, the CDC said the guidance would apply to about 10% of Americans.

Keep reading... Show less

Ripple CEO calls for clearer crypto regulations following SEC lawsuit

Ripple CEO Brad Garlinghouse tells "Axios on HBO" that if his company loses a lawsuit brought by the SEC, it would put the U.S. cryptocurrency industry at a competitive disadvantage.

Why it matters: Garlinghouse's comments may seem self-serving, but his call for clearer crypto rules is consistent with longstanding entreaties from other industry players.

Keep reading... Show less

Republican Sen. Roy Blunt will not seek re-election in 2022

Sen. Roy Blunt (R-Mo.) will not run for re-election in 2022, he announced on Twitter Monday.

Why it matters: The 71-year-old senator is the No. 4-ranking Republican in the Senate, and the fifth GOP senator to announce he will not run for re-election in 2022 as the party faces questions about its post-Trump future.

Keep reading... Show less

COVID Tracking Project officially ends daily updates, citing improved government transparency

The COVID Tracking Project, a volunteer group of data analysts, researchers, and journalists brought together by The Atlantic, published its final daily update on Monday — the one-year anniversary of its founding.

Why it matters: The project quickly became a vital resource for news media, academic researchers, and everyday Americans to track COVID-19 cases, hospitalizations, and deaths in the absence of reliable and public data from the federal government.

Keep reading... Show less

As Congress eyes massive infrastructure bill, energy and climate move closer to center stage

The imminent enactment of Democrats' $1.9 trillion COVID-19 relief package creates space for lawmakers and the White House to craft infrastructure plans with big climate and energy-related provisions.

Why it matters: President Biden, during the campaign, vowed to make low-carbon energy, climate-resilient infrastructure and transportation projects a big focus of an economic recovery package. And the Texas power crisis could give fresh momentum to investments in grid modernization.

Keep reading... Show less



Get Goodhumans in your inbox

Most Read

More Stories